Is Finite-Duration Therapy the New Frontline Standard of Care for CLL?

Moving towards time-limited treatment in frontline CLLПодробнее

CLL14: feasibility of fixed-duration frontline therapy in CLLПодробнее

Unanswered questions in frontline CLL treatmentПодробнее

Ibrutinib’s Role as Frontline Therapy in CLLПодробнее

Chronic Lymphocytic Leukemia (CLL): Changes in frontline treatmentПодробнее

Challenges of selecting frontline therapy in CLLПодробнее

Selecting Frontline Therapy for CLLПодробнее

Current Standard of Care for Frontline CLLПодробнее

Targeted Therapy Options for Frontline CLLПодробнее

Maintenance and Frontline Therapy in CLLПодробнее

Factors to consider when selecting initial therapy in CLL: patient features & preferenceПодробнее

The evolution of frontline treatment for CLL: from chemoimmunotherapy to targeted agentsПодробнее

Frontline therapies for treatment naive CLL patientsПодробнее

Frontline treatment for CLL: the changing paradigmПодробнее

Additional Insights: Treatment Regimens in CLLПодробнее

Front-line treatment options for CLL | Dr. Jeff Sharman | Oncology Brothers #2023Подробнее

Update on CLL/SLL for Newly Diagnosed Patients | LRF WebinarsПодробнее

Dr. Wierda on Frontline Therapy for Older CLL Patients Compared to YoungerПодробнее

Advances in Frontline Therapy for CLLПодробнее